Opinion: Erase science's blacklist

A researcher recently found guilty of misconduct argues that he—and all other penalized scientists—still have a valuable place in science.

Written bySuresh Radhakrishnan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I joined Dr. Larry Pease's laboratory as a fellow in 2001, where I studied the effect of a human IgM antibody on T cell activation. I am grateful to Larry—a remarkable scientist, an incredible human, an amazing mentor, and a valuable member of the Mayo Clinic—and the prestigious Mayo Clinic for providing me with a wonderful opportunity to be a part of their team. During my 9 years at Mayo, we showed that the antibody was capable of inducing immunostimulatory effects in both in vivo and in vitro experimental model systems.

Recently, however, none of these previously identified effects stimulated by antibody binding was observed. Based on circumstantial observations, it was claimed that I fabricated an experiment designed to quantify the potency of the purified antibody. As a result, multiple papers were retracted, a clinical trial was canceled, and my appointment at the Mayo clinic was terminated. Without harping too ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform